AP-1 |
Activator protein 1 |
APC |
Antigen-presenting cell |
Acp |
ε-aminocaproic acid residue |
BSA |
Bovine serum albumin |
CTL |
Cytotoxic T lymphocyte |
CTLA-4 |
Cytotoxic T-lymphocyte-associated protein 4 |
DMEM |
Dulbecco’s modified Eagle medium |
DTT |
Dithiothreitol |
ECL |
Enhanced chemiluminescence |
EDTA |
Ethylenediaminetetraacetic acid |
ELISA |
Enzyme-linked immunosorbent assay |
FBS |
Fetal bovine serum |
FITC |
Fluorescein isothiocyanate |
HPLC |
High-performance liquid chromatography |
irAEs |
Immune-related adverse events |
IL-2 |
Interleukin 2 |
IFN-γ |
Interferon-gamma |
IU |
International unit |
MST |
Microscale thermophoresis |
LDH |
Lactate dehydrogenase |
mAb |
Monoclonal antibody |
MHC |
Majorhistocompatibilitycomplex |
MOE |
Molecular operating environment |
NF-κB |
Nuclear factor kappa-B |
PBMCs |
Peripheral blood mononuclear cells |
PBS |
Phosphate buffered saline |
PD-1 |
Programmedcelldeathprotein1 |
PD-L1 |
Programmeddeath-ligand1 |
PD-L2 |
Programmeddeath-ligand2 |
PVDF |
Polyvinylidene fluoride |
SPPS |
Solid-phase peptide synthesis |
TBST |
Tris-buffered saline solution with 0.05% Tween |
TCR |
T cell receptor |
PMSF |
Phenylmethanesulfonyl fluoride |